STRIKER TO BUY NOVADAQ!

Discussion in 'Stryker' started by anonymous, Jun 19, 2017 at 8:49 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Thoughts on how it will play out?
     

  2. anonymous

    anonymous Guest

    Acquisition is more defensive than offensive. Premium like that indicates there was a bidding war. Look out for the Stryker lawyers unload on anyone infringing on the huge NVDQ patent portfolio. But it also let's Stryker go head to head with Storz and Olympus in the ICG and NBI markets. Roll the IP into the Stryker Endo suite and start cashing checks!
     
  3. anonymous

    anonymous Guest

    ICG is different technology to Storz SPIES and Olympus NBI. And Stryker is already promoting ICG in the 1588 platform.

    They've just acquired the only other current ICG technology I'm aware of at a massive premium.

    Very interesting.
     
  4. anonymous

    anonymous Guest

    Novadaq has been for sale for years. Why buy them now at a huge premium?
     
  5. anonymous

    anonymous Guest

    Stryker buys them now because someone else tried to buy them?
     
  6. anonymous

    anonymous Guest

    Last few big purchases have been way overvalued. Someone needs to read the art of the deal.
     
  7. anonymous

    anonymous Guest

    So do we make room for Novadaq sales force or cut them all and pile on more things for us to do?
     
  8. anonymous

    anonymous Guest

    love the technology from Nova and can see it being a huge value add for us. Does this mean that are spending spree is done for the year with a huge acqusition like Novadaq? Are we out of the neurostimulation pool and whats next on the buying block?
     
  9. anonymous

    anonymous Guest

    Actually its the Stryker reps that will be RIFd in MASS Numbers. Stryker overspent on this acquisition and you'll see the impact by fall. If you dont think so, then you're a damn blind fool.
     
  10. anonymous

    anonymous Guest

    Learn to spell "STRYKER" before you start a thread OP troll moron !!!!!!!!!!!!
     
  11. anonymous

    anonymous Guest

    The idiots that run this company will probably fire all the Novadaq reps, and dump more shit on us! The Novadaq rep that I run into, really knows his shit, and seems to be well liked by docs and staff alike. Let them do their thing! We have enough to do!!!
     
  12. anonymous

    anonymous Guest

    Definitely true, Its already pre-planned by HR
     
  13. anonymous

    anonymous Guest

    Come on. Novadaq probably has a grand total of 50 reps in North America. They'll keep some, dump some, and bring in Stryker guys to fill the gaps. Total sales head count to remain about the same. Stryker will slash Novadaq G&A, and a big chunk of R&D. Those are where they'll find the synergies, not in net sales force reductions.
     
  14. anonymous

    anonymous Guest

    Still way to much money for this company.
     
  15. anonymous

    anonymous Guest

    Sounds like another player is about the make a higher bid for Novadaq. JnJ? Medtronic? Intuitive? Suppose that Stryker will counter but this is a fun game to watch.
     
  16. anonymous

    anonymous Guest

    I think you will still see some kind of neuromodulation play by the end of the year